|
FY2023
12 months to Mar 4, 2023
|
FY2022
12 months to Feb 26, 2022
|
FY2021
12 months to Feb 27, 2021
|
FY2020
12 months to Feb 29, 2020
|
FY2019
12 months to Mar 2, 2019
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss | |||||
| Net income from discontinued operations, net of tax | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile to net cash (used in) provided by operating activities of continuing operations: | |||||
| Depreciation and amortization | |||||
| Lease termination and impairment charges | |||||
| Facility exit and impairment charges | |||||
| Goodwill and intangible asset impairment charges | |||||
| LIFO charge (credit) | |||||
| (Gain) loss on sale of assets, net | |||||
| Gain on Bartell acquisition | |||||
| Change in allowances for uncollectible accounts receivable | |||||
| Loss (gain) on Bartell acquisition | |||||
| Stock-based compensation expense | |||||
| (Gain) loss on debt modifications and retirements, net | |||||
| Changes in deferred taxes | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Accounts payable | |||||
| Operating lease right-of-use assets and operating lease liabilities | |||||
| Other assets | |||||
| Other liabilities | |||||
| Net cash (used in) provided by operating activities of continuing operations: | |||||
| Investing activities: | |||||
| Payments for property, plant and equipment | |||||
| Intangible assets acquired | |||||
| Acquisition of business, net of cash acquired | |||||
| Proceeds from insured loss | |||||
| Proceeds from dispositions of assets and investments | |||||
| Proceeds from sale-leaseback transactions | |||||
| Net cash used in investing activities of continuing operations: | |||||
| Financing activities: | |||||
| Proceeds from issuance of long-term debt | |||||
| Net proceeds from (payments to) revolver | |||||
| Principal payments on long-term debt | |||||
| Change in zero balance cash accounts | |||||
| Net proceeds from issuance of common stock | |||||
| Financing fees paid for early debt redemption | |||||
| Payments for taxes related to net share settlement of equity awards | |||||
| Deferred financing costs paid | |||||
| Net cash provided by (used in) financing activities of continuing operations: | |||||
| Cash flows from discontinued operations: | |||||
| Operating activities of discontinued operations | |||||
| Investing activities of discontinued operations | |||||
| Financing activities of discontinued operations | |||||
| Net cash provided by discontinued operations | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
Loading...